Solutions to Improve Nurse Workflow and Patient Safety on Display in Booth #1403
Mountain View, CA /PRNewswire/ - Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will feature its award-winning platform of solutions at the American Organization of Nurse Executives (AONE) 2018 conference, taking place April 12-15 in Indianapolis at the Indiana Convention Center. Omnicell's industry-leading medication management platform leverages automation and predictive analytics to simplify nurse workflows and reduce medication errors to help improve patient safety.
A clinical study highlighted that Omnicell® systems significantly increase nursing workflow efficiency, as evidenced by a 40 percent reduction in time from initial order to first dose administration of antibiotics.1 Omnicell's solutions help to maximize nurses' time, allowing them to spend more time with patients and increase job satisfaction rates.
Omnicell's workflow solutions and analytics tools will be on display at AONE 2018 in booth #1403. Solutions available in the booth for demonstration include:
"At Omnicell, we understand the vital role nurses play in contributing to patient care, especially the impact their time at the bedside has on patient outcomes and satisfaction," said That H. Ngo, executive vice president, marketing, strategy, and business development at Omnicell. "We're excited to attend AONE 2018 and showcase how we work with nurses to maximize their time and positively impact care."
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.
Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
For more information about Omnicell, Inc. please visit www.omnicell.com.
All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
All other brand or product names may be trademarks or registered trademarks of their respective companies.
1 Time to first dose for piperacillin-tazobactam was measured using the Omnicell automated dispensing system in comparison to a competitive system previously used at Hackensack University Medical Center. Results were presented by Hackensack UMC at the New Jersey Society of Health-System Pharmacists annual meeting on April 24, 2015.
2 Rapid City Regional Hospital, 2014.
SOURCE: Omnicell, Inc.Copyright 2018 PR Newswire. All Rights Reserved